Klaudia Bartoszewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Klaudia Bartoszewicz has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anna Borkowska
Department of Pediatrics, Gastroenterology, Allergology and Nutrition, Medical University of Gdańsk, 80-803 Gdańsk, Poland
3 shared publications - Hanna Romanowska
Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University, 71-252 Szczecin, Poland
3 shared publications - Janusz Książyk
Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, 04-730 Warsaw, Poland
3 shared publications - Joanna Wielopolska
Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University, 71-252 Szczecin, Poland
3 shared publications - Joanna Żydak
The Children’s Memorial Health Institute, Department of Pediatrics, Nutrition and Metabolic Diseases, 04-730 Warsaw, Poland
3 shared publications - Katarzyna Popińska
The Children’s Memorial Health Institute, Department of Pediatrics, Nutrition and Metabolic Diseases, 04-730 Warsaw, Poland
3 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by VM Media Group sp. z o.o in Child Neurology
- Vol. 63 (35) , 17-23
Dwuletnie retrospektywne badanie wpływu terapii dietą ketogenną na stan odżywienia i wzrost u dzieci
Introduction: The ketogenic diet (KD) is widely used as an effective therapeutic option for drug-resistant epilepsy. Despite its clinical benefits, concerns remain regarding its potential impact on growth and nutritional status, particularly in children undergoing long-term treatment. Objective: To assess growth trajectories during long-term KD treatment. Material and methods: The study cohort comprised 20 patients aged between 24 months and 15 years and 2 months, who were undergoing treatment with either the classical ketogenic diet or the modified Atkins diet. A retrospective analysis of medical records was conducted to evaluate height, weight, and body mass index (BMI) Z-scores at baseline, 12 months, and 24 months. Results: No significant deceleration in weight gain on KD was observed, and weight Z-scores remained relatively stable across the 24-month period. In contrast, a statistically significant decline in height Z-score occurred during the first 12 months of KD, with 60% of patients (12/20) showing a reduction greater ΔZ-score < –1 (p < 0.001), indicating a marked impact on linear growth in the early phase of treatment. Between 12 and 24 months, height Z-scores showed a trend toward partial catch-up growth; however, this improvement was not statistically significant (p = 0.053). Additionally, BMI Z-score was significantly higher at 12 months compared to both baseline (p = 0.002) and 24 months (p = 0.022), potentially reflecting the impact of reduced height velocity rather than true improvements in nutritional status. Conclusions: The ketogenic diet may impair linear growth, particularly during the first year of therapy, while weight remains largely unaffected. However, further research is needed to explore the long-term effects of the KD on growth and metabolism, especially in pediatric populations. Keywords: ketogenic diet drug-resistant epilepsy nutritional status growth
- 1 July 2025
- Published by VM Media Group sp. z o.o in Child Neurology
- Vol. 63 (35) , 17-23
Open AccessDwuletnie retrospektywne badanie wpływu terapii dietą ketogenną na stan odżywienia i wzrost u dzieci
Introduction: The ketogenic diet (KD) is widely used as an effective therapeutic option for drug-resistant epilepsy. Despite its clinical benefits, concerns remain regarding its potential impact on growth and nutritional status, particularly in children undergoing long-term treatment. Objective: To assess growth trajectories during long-term KD treatment. Material and methods: The study cohort comprised 20 patients aged between 24 months and 15 years and 2 months, who were undergoing treatment with either the classical ketogenic diet or the modified Atkins diet. A retrospective analysis of medical records was conducted to evaluate height, weight, and body mass index (BMI) Z-scores at baseline, 12 months, and 24 months. Results: No significant deceleration in weight gain on KD was observed, and weight Z-scores remained relatively stable across the 24-month period. In contrast, a statistically significant decline in height Z-score occurred during the first 12 months of KD, with 60% of patients (12/20) showing a reduction greater ΔZ-score < –1 (p < 0.001), indicating a marked impact on linear growth in the early phase of treatment. Between 12 and 24 months, height Z-scores showed a trend toward partial catch-up growth; however, this improvement was not statistically significant (p = 0.053). Additionally, BMI Z-score was significantly higher at 12 months compared to both baseline (p = 0.002) and 24 months (p = 0.022), potentially reflecting the impact of reduced height velocity rather than true improvements in nutritional status. Conclusions: The ketogenic diet may impair linear growth, particularly during the first year of therapy, while weight remains largely unaffected. However, further research is needed to explore the long-term effects of the KD on growth and metabolism, especially in pediatric populations. Keywords: ketogenic diet drug-resistant epilepsy nutritional status growth
- Open Access
The Impact of Long-Term Parenteral Nutrition on Physical Development and Bone Mineralization in Children with Chronic Intestinal Failure
Background: This cross-sectional study aimed to assess growth, body weight, and bone mineralization and to identify predictors of metabolic bone disease (MBD) in children with chronic intestinal failure (CIF) on long-term parenteral nutrition (LPN). Methods: Twenty-six children with CIF were evaluated on total parenteral nutrition (PN) for at least three years, and 60 healthy controls were assessed. Measurements included body weight, height, BMI, serum levels of 25-hydroxyvitamin D3 (25-OHD3), calcium (Ca), phosphorus (P), magnesium (Mg), and aluminum (Al), as well as urinary excretion of these elements. Dual-energy X-ray absorptiometry (DXA) and the mid-arm muscle area (MAMA) and mid-arm fat area (MAFA) of the CIF group were estimated. Results: CIF children had significantly lower height, weight, and BMI Z-scores than controls (p < 0.001). While the median bone mineral density (BMD) Z-score was >−2, 34.7% had L1–L4 Z-scores ≤ −2. Urinary Ca and Al excretion were higher in LPN patients, positively correlating with serum 25-OHD3 levels (r = 0.48). Lower serum Ca, P, and Mg were observed in LPN patients (p < 0.001), and BMC L1–L4 correlated positively with MAMA, MAFA, and BMI. Conclusions: The physical development of children who require long-term parenteral nutrition due to intestinal failure is poorer than that of healthy children. Although there are risk factors for bone mineralization disorders in children with intestinal failure, no clinical issues, such as pathological fractures, have been observed.
Open AccessThe Impact of Long-Term Parenteral Nutrition on Physical Development and Bone Mineralization in Children with Chronic Intestinal Failure
Background: This cross-sectional study aimed to assess growth, body weight, and bone mineralization and to identify predictors of metabolic bone disease (MBD) in children with chronic intestinal failure (CIF) on long-term parenteral nutrition (LPN). Methods: Twenty-six children with CIF were evaluated on total parenteral nutrition (PN) for at least three years, and 60 healthy controls were assessed. Measurements included body weight, height, BMI, serum levels of 25-hydroxyvitamin D3 (25-OHD3), calcium (Ca), phosphorus (P), magnesium (Mg), and aluminum (Al), as well as urinary excretion of these elements. Dual-energy X-ray absorptiometry (DXA) and the mid-arm muscle area (MAMA) and mid-arm fat area (MAFA) of the CIF group were estimated. Results: CIF children had significantly lower height, weight, and BMI Z-scores than controls (p < 0.001). While the median bone mineral density (BMD) Z-score was >−2, 34.7% had L1–L4 Z-scores ≤ −2. Urinary Ca and Al excretion were higher in LPN patients, positively correlating with serum 25-OHD3 levels (r = 0.48). Lower serum Ca, P, and Mg were observed in LPN patients (p < 0.001), and BMC L1–L4 correlated positively with MAMA, MAFA, and BMI. Conclusions: The physical development of children who require long-term parenteral nutrition due to intestinal failure is poorer than that of healthy children. Although there are risk factors for bone mineralization disorders in children with intestinal failure, no clinical issues, such as pathological fractures, have been observed.
- Open Access
Are Trace Elements Provided for Children on Long-Term Parenteral Nutrition Adequate to Meet Their Needs?
Background: We conducted a cross-sectional study to investigate whether children receiving long-term parenteral nutrition (LPN) are at risk of imbalances in selected trace elements. Methods: Serum levels of manganese, zinc, copper, selenium, and iodine were measured in 83 children on LPN and compared with 121 healthy controls. Children with signs of infection or elevated C-reactive protein levels were excluded. Elemental analysis was performed using inductively coupled plasma mass spectrometry (ICP-MS). Results: Manganese and copper levels were significantly lower in the study group compared with controls (p < 0.001) but remained within normal ranges. Iodine levels were also significantly lower in the study group (p < 0.05), though pediatric reference values are lacking. Zinc and selenium levels were significantly higher in the study group (p < 0.001), with median levels within normal ranges in both groups. Zinc, selenium, and iodine levels were higher in patients weighing ≤15 kg (p < 0.001, p < 0.001, p < 0.02). Conclusions: Serum concentrations of manganese, copper, and selenium in the study group remained within normal ranges, even though children weighing over 15 kg received doses below those recommended by scientific guidelines. An iodine intake below 1 μg/kg/day in patients weighing over 15 kg appears insufficient. Patients on LPN required a higher zinc intake than current recommendations.
Open AccessAre Trace Elements Provided for Children on Long-Term Parenteral Nutrition Adequate to Meet Their Needs?
Background: We conducted a cross-sectional study to investigate whether children receiving long-term parenteral nutrition (LPN) are at risk of imbalances in selected trace elements. Methods: Serum levels of manganese, zinc, copper, selenium, and iodine were measured in 83 children on LPN and compared with 121 healthy controls. Children with signs of infection or elevated C-reactive protein levels were excluded. Elemental analysis was performed using inductively coupled plasma mass spectrometry (ICP-MS). Results: Manganese and copper levels were significantly lower in the study group compared with controls (p < 0.001) but remained within normal ranges. Iodine levels were also significantly lower in the study group (p < 0.05), though pediatric reference values are lacking. Zinc and selenium levels were significantly higher in the study group (p < 0.001), with median levels within normal ranges in both groups. Zinc, selenium, and iodine levels were higher in patients weighing ≤15 kg (p < 0.001, p < 0.001, p < 0.02). Conclusions: Serum concentrations of manganese, copper, and selenium in the study group remained within normal ranges, even though children weighing over 15 kg received doses below those recommended by scientific guidelines. An iodine intake below 1 μg/kg/day in patients weighing over 15 kg appears insufficient. Patients on LPN required a higher zinc intake than current recommendations.
- Open Access
Unexpected Serum and Urine Aluminum Concentrations in Pediatric Patients on Home Parenteral Nutrition
The intravenous supply of aluminum (Al) present in parenteral nutrition solutions poses a high risk of the absorption of this element, which can result in metabolic bone disease, anemia, and neurological complications. The aim of this study is to determine the impact of long-term parenteral nutrition (PN) in children on serum Al concentration and its urinary excretion compared to healthy children. We evaluated serum Al concentrations and its urinary excretion in patients enrolled in the Polish home parenteral nutrition (HPN) program between 2004 and 2022. The study group included 83 patients and the control group consisted of 121 healthy children. In children whose PN was started in the neonatal period, we found higher serum Al concentrations and higher urinary Al excretion than in other subjects whose PN was started later. Only 12% of the children on chronic parenteral nutrition had serum Al concentrations of less than 5 μg/L. Healthy children in the control group had higher serum Al concentrations than those in the parenteral nutrition group, which may indicate the influence of one’s environment and diet on Al serum levels.
Open AccessUnexpected Serum and Urine Aluminum Concentrations in Pediatric Patients on Home Parenteral Nutrition
The intravenous supply of aluminum (Al) present in parenteral nutrition solutions poses a high risk of the absorption of this element, which can result in metabolic bone disease, anemia, and neurological complications. The aim of this study is to determine the impact of long-term parenteral nutrition (PN) in children on serum Al concentration and its urinary excretion compared to healthy children. We evaluated serum Al concentrations and its urinary excretion in patients enrolled in the Polish home parenteral nutrition (HPN) program between 2004 and 2022. The study group included 83 patients and the control group consisted of 121 healthy children. In children whose PN was started in the neonatal period, we found higher serum Al concentrations and higher urinary Al excretion than in other subjects whose PN was started later. Only 12% of the children on chronic parenteral nutrition had serum Al concentrations of less than 5 μg/L. Healthy children in the control group had higher serum Al concentrations than those in the parenteral nutrition group, which may indicate the influence of one’s environment and diet on Al serum levels.